12-51118703-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000548108.1(TFCP2):c.-103C>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
ENST00000548108.1 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TFCP2 | NM_005653.5 | c.192C>G | p.Ile64Met | missense_variant | Exon 2 of 15 | ENST00000257915.10 | NP_005644.2 | |
TFCP2 | NM_001173452.2 | c.192C>G | p.Ile64Met | missense_variant | Exon 2 of 15 | NP_001166923.1 | ||
TFCP2 | NM_001173453.2 | c.192C>G | p.Ile64Met | missense_variant | Exon 2 of 14 | NP_001166924.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.192C>G (p.I64M) alteration is located in exon 2 (coding exon 2) of the TFCP2 gene. This alteration results from a C to G substitution at nucleotide position 192, causing the isoleucine (I) at amino acid position 64 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.